{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:41:41Z","timestamp":1765546901586,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To analyse clinical characteristics, antibiotic susceptibility, and risk factors for mortality in paediatric invasive pneumococcal disease (IPD) in Beijing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Paediatric IPD patients in our hospital were retrospectively collected from 2012 to 2017. Clinical manifestations, laboratory tests, antimicrobial susceptibility and serotype of isolates, and risk factors for mortality of IPD were analysed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 186 IPD cases were enrolled. The major manifestations were meningitis (76), pneumonia with bacteraemia (60), bacteraemia without focus (21), and pneumonia with empyaema (22). Of 72 cases with underlying diseases, leukaemia (18.0%), congenital heart disease (15.3%), primary immunodeficiency disease (12.5%), nephrotic syndrome (12.5%), and cerebrospinal fluid leakage (12.5%) were most common. In total 96.9% of isolates would have been covered by the pneumococcal conjugate vaccine (PCV13), including 19F (32.8%), 19A (23.4%), 4 (17.2%), and 23F (9.4%). Nonsusceptibility rates of penicillin, cefotaxime, and cefepime among nonmeningitis patients increased between 2012 and 2017; The mortality rate was 21.5%. Meningitis, respiratory failure, multiple organ failure, and white blood cell count\u2009&lt;\u20094000 cells\/\u03bcL were independent risk factors for mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Meningitis was the most common clinical manifestation of IPD, and was frequently associated with death. Strains in the PCV13 vaccine would cover most of the cases, and so wider use of PCV13 should be considered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07179-8","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:09:36Z","timestamp":1649156976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical characteristics, antimicrobial resistance, and risk factors for mortality in paediatric invasive pneumococcal disease in Beijing, 2012\u20132017"],"prefix":"10.1186","volume":"22","author":[{"given":"Man","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-hu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-qi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8551-741X","authenticated-orcid":false,"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"7179_CR1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12879-016-1648-2","volume":"16","author":"E Backhaus","year":"2016","unstructured":"Backhaus E, Berg S, Andersson R, Ockborn G, Malmstrom P, Dahl M, et al. Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors. BMC Infect Dis. 2016;16:367.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"7179_CR2","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1542\/peds.103.3.e28","volume":"103","author":"OS Levine","year":"1999","unstructured":"Levine OS, Farley M, Harrison LH, Lefkowitz L, McGeer A, Schwartz B, et al. Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics. 1999;103(3):e28.","journal-title":"Pediatrics"},{"key":"7179_CR3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2147\/IDR.S183916","volume":"11","author":"K Cai","year":"2018","unstructured":"Cai K, Wang Y, Guo Z, Xu X, Li H, Qingli Z, et al. Clinical characteristics and antimicrobial resistance of pneumococcal isolates of pediatric invasive pneumococcal disease in China. Infect Drug Resis. 2018;11:2461\u20139.","journal-title":"Infect Drug Resis"},{"key":"7179_CR4","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1017\/S0950268819000657","volume":"147","author":"C Houseman","year":"2019","unstructured":"Houseman C, Chapman KE, Manley P, Gorton R, Wilson D, Hughes GJ, et al. Decreasing case fatality rate following invasive pneumococcal disease, North East England, 2006\u20132016. Epidemiol Infect. 2019;147:e175.","journal-title":"Epidemiol Infect"},{"issue":"6","key":"7179_CR5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/655828","volume":"51","author":"DM Weinberger","year":"2010","unstructured":"Weinberger DM, Harboe ZB, Sanders EA, Ndiritu M, Klugman KP, Ruckinger S, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis. 2010;51(6):692\u20139.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"7179_CR6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3201\/eid2103.140634","volume":"21","author":"A Navarro-Torne","year":"2015","unstructured":"Navarro-Torne A, Dias JG, Hruba F, Lopalco PL, Pastore-Celentano L, Gauci AJ, et al. Risk factors for death from invasive pneumococcal disease, Europe, 2010. Emerg Infect Dis. 2015;21(3):417\u201325.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"7179_CR7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/cid\/cix310","volume":"65","author":"G Oligbu","year":"2017","unstructured":"Oligbu G, Collins S, Sheppard CL, Fry NK, Slack M, Borrow R, et al. Childhood Deaths Attributable to Invasive Pneumococcal Disease in England and Wales, 2006\u20132014. Clin Infect Dis. 2017;65(2):308\u201314.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7179_CR8","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1542\/peds.2007-1510","volume":"122","author":"T Hjuler","year":"2008","unstructured":"Hjuler T, Wohlfahrt J, Staum KM, Koch A, Biggar RJ, Melbye M, et al. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics. 2008;122(1):e26-32.","journal-title":"Pediatrics"},{"issue":"5","key":"7179_CR9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1590\/S0036-36342010000500006","volume":"52","author":"D G\u00f3mez-Barreto","year":"2010","unstructured":"G\u00f3mez-Barreto D, Espinosa-Monteros LE, L\u00f3pez-Enr\u00edquez C, Jim\u00e9nez-Rojas V, Rodr\u00edguez-Su\u00e1rez R. Invasive pneumococcal disease in a third level pediatric hospital in Mexico City: Epidemiology and mortality risk factors. Salud P\u00fablica De M\u00e9xico. 2010;52(5):391\u20137.","journal-title":"Salud P\u00fablica De M\u00e9xico"},{"issue":"4","key":"7179_CR10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jmii.2016.12.004","volume":"51","author":"HY Lee","year":"2018","unstructured":"Lee HY, Wu TL, Su LH, Li HC, Janapatla RP, Chen CL, et al. Invasive pneumococcal disease caused by ceftriaxone-resistant Streptococcus pneumoniae in Taiwan. J Microbiol Immunol Infect. 2018;51(4):500\u20139.","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"7179_CR11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1086\/650534","volume":"50","author":"L Xue","year":"2010","unstructured":"Xue L, Yao K, Xie G, Zheng Y, Wang C, Shang Y, et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates that cause invasive disease among Chinese children. Clin Infect Dis. 2010;50(5):741\u20134.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7179_CR12","doi-asserted-by":"crossref","first-page":"e54254","DOI":"10.1371\/journal.pone.0054254","volume":"8","author":"C Liu","year":"2013","unstructured":"Liu C, Xiong X, Xu W, Sun J, Wang L, Li J, et al. Serotypes and patterns of antibiotic resistance in strains causing invasive pneumococcal disease in children less than 5 years of age. PLoS ONE. 2013;8(1):e54254.","journal-title":"PLoS ONE"},{"issue":"3","key":"7179_CR13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/INF.0000000000001000","volume":"35","author":"S Lyu","year":"2016","unstructured":"Lyu S, Yao KH, Dong F, Xu BP, Liu G, Wang Q, et al. Vaccine serotypes of Streptococcus pneumoniae with high-level antibiotic resistance isolated more frequently seven years after the licensure of PCV7 in Beijing. Pediatr Infect Dis J. 2016;35(3):316\u201321.","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"7179_CR14","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1128\/jcm.31.8.2097-2100.1993","volume":"31","author":"UB S\u00f8rensen","year":"1993","unstructured":"S\u00f8rensen UB. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol. 1993;31(8):2097\u2013100.","journal-title":"J Clin Microbiol"},{"issue":"33","key":"7179_CR15","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1016\/j.vaccine.2017.06.046","volume":"35","author":"X Zhang","year":"2017","unstructured":"Zhang X, Tian J, Shan W, Xue J, Tao Y, Geng Q, et al. Characteristics of pediatric invasive pneumococcal diseases and the pneumococcal isolates in Suzhou, China before introduction of PCV13. Vaccine. 2017;35(33):4119\u201325.","journal-title":"Vaccine"},{"issue":"3","key":"7179_CR16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1473-3099(16)30466-2","volume":"17","author":"A Manoharan","year":"2017","unstructured":"Manoharan A, Manchanda V, Balasubramanian S, Lalwani S, Modak M, Bai S, et al. Invasive pneumococcal disease in children aged younger than 5 years in India: a surveillance study. Lancet Infect Dis. 2017;17(3):305\u201312.","journal-title":"Lancet Infect Dis"},{"key":"7179_CR17","doi-asserted-by":"crossref","first-page":"e2941","DOI":"10.7717\/peerj.2941","volume":"5","author":"NC Chiu","year":"2017","unstructured":"Chiu NC, Chi H, Peng CC, Chang HY, Huang DT, Chang L, et al. Retrospective study of prognostic factors in pediatric invasive pneumococcal disease. Peer J. 2017;5:e2941.","journal-title":"Peer J"},{"issue":"7","key":"7179_CR18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/cid\/cix418","volume":"65","author":"G Oligbu","year":"2017","unstructured":"Oligbu G, Collins S, Andrews N, Sheppard CL, Fry NK, Slack MPE, et al. Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006\u20132014. Clin Infect Dis. 2017;65(7):1191\u20138.","journal-title":"Clin Infect Dis"},{"key":"7179_CR19","unstructured":"Centers for Disease Control and Prevention. Active bacterial core surveillance(ABCs) report: emerging infections program network, streptococcus pneumoniae, 2017. http:\/\/www.cdc.gov\/abcs\/reportsfindings\/survreports\/spneu17.pdf."},{"key":"7179_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijid.2018.06.023","volume":"74","author":"C Li","year":"2018","unstructured":"Li C, Feng W, Lin A, Zheng G, Wang Y, Han Y, et al. Clinical characteristics and etiology of bacterial meningitis in Chinese children >28 days of age, January 2014\u2013December 2016: A multicenter retrospective study. Int J Infect Dis. 2018;74:47\u201353.","journal-title":"Int J Infect Dis"},{"key":"7179_CR21","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1097\/INF.0000000000002368","volume":"38","author":"A Makwana","year":"2019","unstructured":"Makwana A, Sheppard C, Fry NK, Ladhani SN. Pneumococcal-related Hemolytic Uremic Syndrome in the United Kingdom: National Surveillance, 2006\u20132016. Pediatr Infect Dis J. 2019;38:e254\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"1A","key":"7179_CR22","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1016\/S0002-9343(99)00103-5","volume":"107","author":"SN Taylor","year":"1999","unstructured":"Taylor SN, Sanders CV. Unusual manifestations of invasive pneumococcal infection. Am J Med. 1999;107(1A):12S-27S.","journal-title":"Am J Med"},{"issue":"8","key":"7179_CR23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/INF.0000000000002386","volume":"38","author":"R Malaker","year":"2019","unstructured":"Malaker R, Saha S, Hanif M, Ahmed A, Saha S, Hasanuzzaman M, et al. Invasive Pneumococcal Infections in Children with Nephrotic Syndrome in Bangladesh. Pediatr Infect Dis J. 2019;38(8):798\u2013803.","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"7179_CR24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00006454-200202000-00011","volume":"21","author":"SL Kaplan","year":"2002","unstructured":"Kaplan SL, Mason EJ, Wald E, Tan TQ, Schutze GE, Bradley JS, et al. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J. 2002;21(2):141\u20137.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"7179_CR25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/ciu348","volume":"59","author":"SI Pelton","year":"2014","unstructured":"Pelton SI, Weycker D, Farkouh RA, Strutton DR, Shea KM, Edelsberg J, et al. Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine. Clin Infect Dis. 2014;59(5):615\u201323.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7179_CR26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1471-2334-11-314","volume":"11","author":"RAC Siemieniuk","year":"2011","unstructured":"Siemieniuk RAC, Gregson DB, Gill MJ. The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study. BMC Infect Dis. 2011;11(1):314.","journal-title":"BMC Infect Dis"},{"issue":"20","key":"7179_CR27","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1056\/NEJMoa044113","volume":"352","author":"TR Talbot","year":"2005","unstructured":"Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352(20):2082\u201390.","journal-title":"N Engl J Med"},{"key":"7179_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2015.06.016","volume":"38","author":"LH Falleiros-Arlant","year":"2015","unstructured":"Falleiros-Arlant LH, Berezin EN, Avila-Aguero ML, Pirez MC, Gentile A, Richardson V, et al. Epidemiological burden of invasive pneumococcal disease in children and adolescents with predisposing risk factors. Int J Infect Dis. 2015;38:1\u20136.","journal-title":"Int J Infect Dis"},{"key":"7179_CR29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tmaid.2018.05.016","volume":"24","author":"M van Aalst","year":"2018","unstructured":"van Aalst M, Lotsch F, Spijker R, van der Meer J, Langendam MW, Goorhuis A, et al. Incidence of invasive pneumococcal disease in immunocompromised patients: a systematic review and meta-analysis. Travel Med Infect Dis. 2018;24:89\u2013100.","journal-title":"Travel Med Infect Dis"},{"issue":"8","key":"7179_CR30","first-page":"e201312","volume":"13","author":"H Jiang","year":"2018","unstructured":"Jiang H, Huai Y, Chen H, Uyeki TM, Chen M, Guan X, et al. Invasive Streptococcus pneumoniae infection among hospitalized patients in Jingzhou city, China, 2010\u20132012. PLoS ONE. 2018;13(8):e201312.","journal-title":"PLoS ONE"},{"issue":"13","key":"7179_CR31","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","volume":"285","author":"KA Robinson","year":"2001","unstructured":"Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995\u20131998: Opportunities for prevention in the conjugate vaccine era. JAMA. 2001;285(13):1729\u201335.","journal-title":"JAMA"},{"issue":"5","key":"7179_CR32","doi-asserted-by":"crossref","first-page":"e1000081","DOI":"10.1371\/journal.pmed.1000081","volume":"6","author":"ZB Harboe","year":"2009","unstructured":"Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ, Lambertsen L, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med. 2009;6(5):e1000081.","journal-title":"PLoS Med"},{"issue":"24","key":"7179_CR33","doi-asserted-by":"crossref","first-page":"e15942","DOI":"10.1097\/MD.0000000000015942","volume":"98","author":"C Wang","year":"2019","unstructured":"Wang C, Chen Y, Fang C, Zhou M, Xu H, Jing C, et al. Antibiotic resistance profiles and multidrug resistance patterns of Streptococcus pneumoniae in pediatrics. Medicine. 2019;98(24):e15942.","journal-title":"Medicine"},{"issue":"3","key":"7179_CR34","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/AAC.05658-11","volume":"56","author":"SH Kim","year":"2012","unstructured":"Kim SH, Song J, Chung DR, Thamlikitkul V, Yang Y, Wang H, et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an asian network for surveillance of resistant pathogens (ANSORP) Study. Antimicrob Agents CH. 2012;56(3):1418\u201326.","journal-title":"Antimicrob Agents CH"},{"issue":"1","key":"7179_CR35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/labmed\/lmw059","volume":"48","author":"J Wang","year":"2017","unstructured":"Wang J, Liu F, Ao P, Li X, Zheng H, Wu D, et al. Detection of serotype distribution and drug resistance of Streptococcus pneumoniae isolated from pediatric patients. Lab Med. 2017;48(1):39\u201345.","journal-title":"Lab Med"},{"issue":"1","key":"7179_CR36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12887-019-1722-1","volume":"19","author":"J Fu","year":"2019","unstructured":"Fu J, Yi R, Jiang Y, Xu S, Qin P, Liang Z, et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive diseases in China: a meta-analysis. BMC Pediatr. 2019;19(1):424.","journal-title":"BMC Pediatr"},{"key":"7179_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s42770-019-00198-9","author":"W Men","year":"2019","unstructured":"Men W, Dong Q, Shi W, Yao K. Serotype distribution and antimicrobial resistance patterns of invasive pneumococcal disease isolates from children in mainland China\u2014a systematic review. Braz J Microbiol. 2019. https:\/\/doi.org\/10.1007\/s42770-019-00198-9.","journal-title":"Braz J Microbiol"},{"issue":"1","key":"7179_CR38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12887-017-0900-2","volume":"17","author":"AL Wagner","year":"2017","unstructured":"Wagner AL, Boulton ML, Sun X, Mukherjee B, Huang Z, Harmsen IA, et al. Perceptions of measles, pneumonia, and meningitis vaccines among caregivers in Shanghai, China, and the health belief model: a cross-sectional study. BMC Pediatr. 2017;17(1):143.","journal-title":"BMC Pediatr"},{"issue":"7","key":"7179_CR39","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","volume":"6","author":"B Wahl","year":"2018","unstructured":"Wahl B, O\u2019Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315. Lancet Glob Health. 2018;6(7):e744\u201357.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"7179_CR40","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S1473-3099(20)30492-8","volume":"21","author":"SN Ladhani","year":"2021","unstructured":"Ladhani SN, Andrews N, Ramsay ME. Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK. Lancet Infect Dis. 2021;21(4):e93\u2013102.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"7179_CR41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","volume":"18","author":"SN Ladhani","year":"2018","unstructured":"Ladhani SN, Collins S, Djennad A, Sheppard CL, Borrow R, Fry NK, et al. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study. Lancet Infect Dis. 2018;18(4):441\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"7179_CR42","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1473-3099(18)30349-9","volume":"18","author":"N Ouldali","year":"2018","unstructured":"Ouldali N, Levy C, Varon E, Bonacorsi S, B\u00e9chet S, Cohen R, et al. Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey. Lancet Infect Dis. 2018;18(9):983\u201391.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"7179_CR43","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/S1473-3099(18)30660-1","volume":"19","author":"JA Lewnard","year":"2019","unstructured":"Lewnard JA, Hanage WP. Making sense of differences in pneumococcal serotype replacement. Lancet Infect Dis. 2019;19(6):e213\u201320.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"7179_CR44","first-page":"23","volume":"35","author":"JS Ma","year":"2002","unstructured":"Ma JS, Chen PY, Mak SC, Chi CS, Lau YJ. Clinical outcome of invasive pneumococcal infection in children: a 10-year retrospective analysis. J Microbiol Immunol Infect. 2002;35(1):23\u20138.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"7179_CR45","doi-asserted-by":"crossref","first-page":"e147877","DOI":"10.1371\/journal.pone.0147877","volume":"11","author":"S Hanada","year":"2016","unstructured":"Hanada S, Iwata S, Kishi K, Morozumi M, Chiba N, Wajima T, et al. Host factors and biomarkers associated with poor outcomes in adults with invasive pneumococcal disease. PLoS ONE. 2016;11(1):e147877.","journal-title":"PLoS ONE"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07179-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07179-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07179-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:15:48Z","timestamp":1649157348000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07179-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7179"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07179-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of Beijing Children\u2019s Hospital Affiliated to Capital Medical University (IEC-C-008-A08-V.05.1), Informed consent was waived because this was a retrospectively study. We obtained patient data from the Medical Records and Statistics Room. We analysed the data anonymously. The raw data were permitted by the Ethics Committee of Beijing Children\u2019s Hospital Affiliated to Capital Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"338"}}